Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios

Hiroko KandaDepartment of Allergy and Rheumatology, University of Tokyo,7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, JapanCorrespondence[email protected]

Kazuhiro YokotaDivision of Rheumatology and Applied Immunology, Department of Medicine, Saitama Medical University,Saitama, Japan

Chieko KohnoDivision of Rheumatology and Applied Immunology, Department of Medicine, Saitama Medical University,Saitama, Japan

Tetsuji SawadaDepartment of Allergy and Rheumatology, University of Tokyo,7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Kojiro SatoDepartment of Cell Signaling, Graduate School, Tokyo Medical and Dental University,Tokyo, Japan

Masao YamaguchiDepartment of Allergy and Rheumatology, University of Tokyo,7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Yoshinori KomagataDepartment of Allergy and Rheumatology, University of Tokyo,7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Kota ShimadaDepartment of Rheumatology, Sagamihara National Hospital, National Hospital Organization,Kanagawa, Japan

Kazuhiko YamamotoDepartment of Allergy and Rheumatology, University of Tokyo,7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Toshihide MimuraDivision of Rheumatology and Applied Immunology, Department of Medicine, Saitama Medical University,Saitama, Japan

References